BioSpace News Archive

Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced that topline data from its preclinical SEQURUS-2 study will be presented at the 14th Annual Bioprocessing Summit.

LumiraDx Limited (Nasdaq: LMDX ), a next-generation point of care (POC) diagnostics company, announced it will release its second quarter financial results on Thursday, August 18th, 2022.

Today, Vyant Bio announced that it will release its financial results for the second quarter and first half ended June 30, 2022, on Monday, August 15, 2022.

F-star Therapeutics, Inc. today announced second quarter 2022 financial results and corporate highlights.

Fortress Biotech, Inc. today announced that Triplex, a cytomegalovirus (“CMV”) vaccine being developed by its subsidiary Helocyte, Inc. (“Helocyte”), received a grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (“NIAID/NIH”) that could provide over $20 million in non-dilutive funding.

Surrozen, Inc. today reported financial results for the second quarter of 2022 and provided a corporate update.

Pasithea Therapeutics Corp. today announced positive results from a preclinical proof of concept study of PAS002, its tolerizing vaccine program in multiple sclerosis (“MS”).

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on operational progress for the second quarter ended June 30, 2022.

ProPhase Labs, Inc. today reported its financial and operational results for the second quarter ended June 30, 2022.

Vaxxinity, Inc. today reported financial results for the second quarter ended June 30, 2022.